UnitedHealth Group (NYSE: UNH) was one of the worst-performing large-cap stocks of 2025. For the full year, UNH stock fell roughly 33%.
Table of Contents
The reasons are well known and are more setbacks than any company would like to have. Primary among those concerns were:
- Allegations of fraud and misconduct related to its billing practices.
- Unexpectedly higher medical costs—particularly within its Medicare programs.
- Weak earnings results accompanied by poor forward guidance.
- The company’s CEO abruptly resigned.
Adding to the pressure, a U.S. Senate committee investigating the company’s practices found that UnitedHealth used what it described as “aggressive tactics” to collect diagnosis data that boosted Medicare Advantage payments, according to reporting by The Wall Street Journal.
It’s tough to find a silver lining. But if investors are looking for one, it may be that much of that bad news is now priced into UNH stock.
UNH Just Signaled That Its Turnaround is Finally Here
After multiple quarters of margin deterioration and a catastrophic drop in GAAP EPS to a penny, investors got the turnaround signal they had been waiting for: a medical cost ratio that snapped back to 83.9%, and higher guidance from the company.
For its first quarter, EPS of $7.23 beat by 63 cents. Revenue of $111.72 billion, up 7.2% year over year, beat by $2.06 billion. The company also said its buying back about $2 billion of common stock by the end of the second quarter. It then raised its full-year earnings outlook to more than $18.25 per share on a non-GAAP basis, up from $17.87 expected.
Early Signs Suggest the Long-Awaited Turnaround May Finally be Underway
After several quarters of margin compression and a decline in earnings—including a period where GAAP EPS fell to just a penny—UnitedHealth delivered results that surprised to the upside. The most encouraging signal came from its medical cost ratio (MCR), a key metric that tracks the percentage of premiums spent on medical care.
The company reported an MCR of 83.9%, a notable improvement and a sign that cost pressures may be stabilizing. This metric is closely watched by investors, as even small changes can have a meaningful impact on profitability. The rebound suggests that management may be regaining control over expenses after a challenging period.
Financial performance in the most recent quarter further supported the bullish case. UnitedHealth reported first-quarter earnings per share of $7.23, beating analyst expectations by $0.63. Revenue came in at $111.72 billion, representing a 7.2% increase year over year and exceeding estimates by $2.06 billion.
Beyond the headline numbers, management also took steps to rebuild investor confidence. The company announced plans to repurchase approximately $2 billion of common stock by the end of the second quarter, signaling that it views the shares as undervalued at current levels.
Perhaps most importantly, UnitedHealth raised its full-year earnings outlook. The company now expects to generate more than $18.25 per share on a non-GAAP basis, compared to prior expectations of $17.87. The upward revision indicates growing confidence in the business outlook and suggests that recent improvements may be sustainable.
UnitedHealth Stock Outlook: Is This Turnaround Built to Last?
For investors evaluating UnitedHealth Group, the latest quarter offers a meaningful shift in the narrative. After a prolonged stretch of negative headlines and deteriorating fundamentals, the company is now showing tangible signs of stabilization. The improvement in its medical cost ratio, combined with stronger-than-expected earnings and a raised full-year outlook, suggests that management is beginning to regain operational control.
That said, this is unlikely to be a straight-line recovery. Regulatory scrutiny, particularly around Medicare Advantage practices, remains an overhang that could introduce volatility. Additionally, sustaining margin improvement will be critical, especially if healthcare utilization trends remain unpredictable.
Still, with much of the prior bad news likely priced into the stock, UNH may present an opportunity for long-term investors willing to accept some near-term uncertainty. If the company can continue executing on cost discipline and deliver consistent earnings growth, the recent momentum could mark the early stages of a more durable turnaround.
Leave a Reply